At Asymchem, we’ve gained our knowledge over 20 years helping the world’s top pharma companies launch new therapeutics.
Our eight R&D and manufacturing sites, 7000+ employees and an exemplary regulatory record means we can do it for you.
Including 2600 scientists, 50% hold advanced degrees.
Stellar track record with FDA, NMPA, TGA, and MFDS inspectors.
600+ ongoing clinical and 30+ ongoing commercial projects.
Growing every year in the US, Europe, Japan, China, and Korea
“Asymchem’s ability to identify and provide solutions to difficult challenges, while maintaining outstanding quality under aggressive timelines, has distinguished Asymchem as a top-notch Contract Manufacturing Organization.”
Tom Wagler, Ph.D., VP, CMC Drug Substance Development at Mersana
“ … really nice work enabling and scale-up on this compound”
Principal Scientist, in Large Pharma
“We are impressed with the high competency of all the Asymchem teams, in every aspect of the business, and this gives us lots of confidence in Asymchem.”
Director Global Procurement, at Major US Pharma company
“Great work in manufacturing more than enough RSMs to meet our API demands for our CTM/Validation campaign. You did a great job controlling the purity of these materials. Thank you.”
Director of Synthetic Chemistry, at a Biopharma Company
Thank you! The Asymchem Team did a fantastic job from start to finish in developing, characterizing and validating a scalable, commercially viable HPAPI manufacturing process
VP Drug Development, Mid-sized Biotech
Promoting greener, safer and more reliable pharmaceutical manufacturing.